| Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection | Biliary Malignant Tumors | Recruiting | Phase 1 / Phase 2 | 2026-02-03 | | NCT07368803 |
|---|
| The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy | Hepatoma Resectable | Recruiting | Early phase 1 | 2025-06-26 | | NCT05035108 |
|---|
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | | NCT06026800 |
|---|
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | | NCT06026774 |
|---|
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 1 | 2023-09-11 | | NCT06019702 |
|---|